{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:42:19Z","timestamp":1785782539053,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108358","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:53:48Z","timestamp":1636743228000},"page":"108358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"PB","title":["Inhibition of Interleukin-6 signaling: A novel therapeutic approach to necrotizing enterocolitis"],"prefix":"10.1016","volume":"101","author":[{"given":"Erbu","family":"Yarci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuneyt","family":"Tayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem","family":"Ozturk Yarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ataman","family":"Gonel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Taskin Turkmenoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2021.108358_b0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.semperi.2008.01.004","article-title":"Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention","volume":"32","author":"Lin","year":"2008","journal-title":"Semin. Perinatol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108358_b0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMra1005408","article-title":"Necrotizing enterocolitis","volume":"364","author":"Neu","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2021.108358_b0015","doi-asserted-by":"crossref","first-page":"F182","DOI":"10.1136\/archdischild-2017-313880","article-title":"Incidence of neonatal necrotising enterocolitis in high-income countries: a systematic review","volume":"103","author":"Battersby","year":"2018","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"8","key":"10.1016\/j.intimp.2021.108358_b0020","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1096\/fj.00-0833hyp","article-title":"Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis","volume":"15","author":"Claud","year":"2001","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.intimp.2021.108358_b0025","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0022-3476(05)81124-2","article-title":"Pathology of neonatal necrotizing enterocolitis: a ten-year experience","volume":"117","author":"Ballance","year":"1990","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.intimp.2021.108358_b0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1552-6909.2007.00157.x","article-title":"Treatment outcomes of necrotizing enterocolitis for preterm infants","volume":"36","author":"Carter","year":"2007","journal-title":"J. Obstet. Gynecol. Neonatal. Nurs."},{"issue":"25","key":"10.1016\/j.intimp.2021.108358_b0035","first-page":"111","article-title":"Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. Cochrane Database Syst Rev. Microbiology and management of neonatal necrotizing enterocolitis","volume":"2008","author":"Bury","year":"2001","journal-title":"Am. J. Perinatol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108358_b0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10024-002-0602-z","article-title":"Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts","volume":"6","author":"Hsueh","year":"2003","journal-title":"Pediatr. Dev. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108358_b0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pathophys.2013.11.010","article-title":"Inflammatory signaling in NEC: Role of NF-\u03baB, cytokines and other inflammatory mediators","volume":"21","author":"Hunter","year":"2014","journal-title":"Pathophysiology."},{"issue":"6","key":"10.1016\/j.intimp.2021.108358_b0050","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3476(05)80661-4","article-title":"Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis","volume":"116","author":"Caplan","year":"1990","journal-title":"J. Pediatr."},{"issue":"s396","key":"10.1016\/j.intimp.2021.108358_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1651-2227.1994.tb13235.x","article-title":"Plasma cytokine levels in necrotizing enterocolitis","volume":"83","author":"Morecroft","year":"1994","journal-title":"Acta Paediatr. Suppl."},{"issue":"6","key":"10.1016\/j.intimp.2021.108358_b0060","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/0022-3468(94)90374-3","article-title":"Plasma interleukin-6 and tumour necrosis factor levels as predictors of disease severity and outcome in necrotizing enterocolitis","volume":"29","author":"Morecroft","year":"1994","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.intimp.2021.108358_b0065","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.febslet.2011.03.023","article-title":"Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases","volume":"585","author":"Tanaka","year":"2011","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.intimp.2021.108358_b0070","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1053\/j.gastro.2004.01.012","article-title":"A pilot randomized trial of a human antiinterleukin-6 receptor monoclonal antibody in active Crohn\u2019s disease","volume":"126","author":"Ito","year":"2004","journal-title":"Gastroenterology"},{"issue":"06","key":"10.1016\/j.intimp.2021.108358_b0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-2008-1038951","article-title":"Assessment of a neonatal rat model of necrotizing enterocolitis","volume":"18","author":"Zani","year":"2008","journal-title":"Eur. J. Pediatr. Surg."},{"issue":"6","key":"10.1016\/j.intimp.2021.108358_b0080","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3109\/15513819409037698","article-title":"Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis","volume":"14","author":"Caplan","year":"1994","journal-title":"Pediatr Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108358_b0085","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1203\/01.PDR.0000113463.70435.74","article-title":"Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis","volume":"55","author":"Jilling","year":"2004","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.intimp.2021.108358_b0090","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/0016-5085(84)90202-6","article-title":"Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models","volume":"87","author":"Krawisz","year":"1984","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.intimp.2021.108358_b0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1535370219891971","article-title":"Necrotizing enterocolitis: It\u2019s not all in the gut","volume":"245","author":"Meister","year":"2020","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2021.108358_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging","volume":"187","author":"Bell","year":"1978","journal-title":"Ann. Surg."},{"issue":"suppl 3","key":"10.1016\/j.intimp.2021.108358_b0105","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1186\/ar565","article-title":"The paradigm of IL-6: from basic science to medicine","volume":"4","author":"Naka","year":"2002","journal-title":"Arthritis Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.108358_b0110","first-page":"145","article-title":"Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction","volume":"16","author":"Wang","year":"2015","journal-title":"Bosn J. Basic Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.108358_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3164\/jcbn.11-006FR","article-title":"Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention","volume":"48","author":"Davies","year":"2010","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"2","key":"10.1016\/j.intimp.2021.108358_b0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcjo.2012.12.003","article-title":"Effects of sub-conjunctivally injected bevacizumab, etanercept, and the combination of both drugs on experimental corneal neovascularization","volume":"48","author":"Ozdemir","year":"2013","journal-title":"Can. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108358_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/02713683.2014.914541","article-title":"Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats","volume":"40","author":"Sari","year":"2015","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.108358_b0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.semperi.2008.01.003","article-title":"The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis","volume":"32","author":"Nankervis","year":"2008","journal-title":"Semin. Perinatol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108358_b0135","first-page":"609","article-title":"Therapeutic effect of exogenous ghrelin in the healing of gingival ulcers is mediated by the release of endogenous growth hormone and insulin-like growth factor-1","volume":"68","author":"Cieszkowski","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108358_b0140","first-page":"95","article-title":"Involvement of cyclooxygenase-1 and cyclooxygenase-2 activity in the therapeutic effect of ghrelin in the course of ethanol-induced gastric ulcers in rats","volume":"65","author":"Warzecha","year":"2014","journal-title":"J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108358_b0145","article-title":"Administration of warfarin accelerates the recovery in ischemia\/reperfusion-induced acute pancreatitis","volume":"71","author":"Maduzia","year":"2020","journal-title":"J. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108358_b0150","doi-asserted-by":"crossref","first-page":"BR181","DOI":"10.12659\/MSM.882727","article-title":"Ghrelin accelerates the healing of cysteamine-induced duodenal ulcers in rats","volume":"18","author":"Warzecha","year":"2012","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"10.1016\/j.intimp.2021.108358_b0155","first-page":"920","article-title":"Pretreatment with obestatin inhibits the development of acetic acid-induced colitis in rats","volume":"14","author":"Matuszyk","year":"2018","journal-title":"Arch. Med. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2021.108358_b0160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1542\/pir.2017-0002","article-title":"Necrotizing Enterocolitis","volume":"38","author":"Rich","year":"2017","journal-title":"Pediatr. Rev."},{"key":"10.1016\/j.intimp.2021.108358_b0165","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2165\/00003495-200868090-00004","article-title":"Necrotizing enterocolitis in newborns: pathogenesis, prevention and management","volume":"68","author":"Thompson","year":"2008","journal-title":"Drugs."},{"issue":"4","key":"10.1016\/j.intimp.2021.108358_b0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/08941939.2011.568594","article-title":"Tumor necrosis factor-\u03b1 in liver ischemia\/reperfusion injury","volume":"24","author":"Perry","year":"2011","journal-title":"J. Invest. Surg."},{"issue":"6","key":"10.1016\/j.intimp.2021.108358_b0175","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00264-013-2261-2","article-title":"Cytokine levels (IL-4, IL-6, IL-8 and TGF\u03b2) as potential biomarkers of systemic inflammatory response in trauma patients","volume":"38","author":"Volpin","year":"2014","journal-title":"Int. Orthop."},{"issue":"1","key":"10.1016\/j.intimp.2021.108358_b0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1995-7645(14)60186-3","article-title":"Protective function of tocilizumab in human cardiac myocytes ischemia reperfusion injury","volume":"8","author":"Cheng","year":"2015","journal-title":"Asian Pac J Trop Med."},{"key":"10.1016\/j.intimp.2021.108358_b0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1203\/00006450-200102000-00021","article-title":"Activation of nuclear factor-kappa B and its suppression by dexamethasone in polymorphonuclear leukocytes: newborn versus adult","volume":"49","author":"Vancurova","year":"2001","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.intimp.2021.108358_b0190","first-page":"768","article-title":"Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: a cumulative analysis of up to 4.6 years of exposure","volume":"40","author":"Genovese","year":"2013","journal-title":"Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108358_b0195","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar3455","article-title":"Integrated safety in tocilizumab clinical trials","volume":"13","author":"Schiff","year":"2011","journal-title":"Arthritis Res Ther."},{"issue":"26\u20137","key":"10.1016\/j.intimp.2021.108358_b0200","article-title":"A case series of patients with rheumatoid arthritis exposed to tocilizumab during pregnancy","volume":"48","author":"Salonga","year":"2018","journal-title":"Intern Med J"},{"key":"10.1016\/j.intimp.2021.108358_b0205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1297-319X(14)70020-X","article-title":"Biologic targeted therapies in pediatric rheumatology","volume":"81","author":"Guillaume-Czitrom","year":"2014","journal-title":"Joint Bone Spine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:42:35Z","timestamp":1761586955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921009942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":41,"alternative-id":["S1567576921009942"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108358","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Interleukin-6 signaling: A novel therapeutic approach to necrotizing enterocolitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108358"}}